Swiss Re Insurance-Linked Fund Management

PCS - Emerging Risks, New Opportunities



RMS performs risk analysis for Vita Capital IV swine flu cat bond

1st December 2009

Risk Management Solutions have released a few more details about their role in the recent Swiss Re mortality transaction Vita Capital IV Ltd. The transaction gives Swiss Re more coverage to allow for any increased mortality which results from H1N1 swine flu.  It’s the first deal of its kind being a mortality transaction which uses […]

Read the full article

Swiss Re completes new Vita Capital IV Ltd. mortality bond

24th November 2009

Swiss Re have now completed their latest life insurance securitization, Vita Capital IV Ltd. The mortality bond transaction provides Swiss Re with $75m of cover against severe population mortality in the U.S. or the UK. The deal covers a five-year risk period ending in 2014. The notes issued by Vita Capital have been rated ‘BB+’ […]

Read the full article